Maintenance immunotherapy in advanced urothelial cancer
Advanced urothelial carcinoma usually responds to platinum-based chemotherapy (CT), although overall survival (OS) and progression-free survival are typically short. Immunotherapy is a promising treatment strategy, but the first-line benefits in platinum-eligible patients are limited, and its combin...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Permanyer
2022-07-01
|
| Serie: | Gaceta Mexicana de Oncología |
| Soggetti: | |
| Accesso online: | https://www.gamo-smeo.com/frame_esp.php?id=323 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|